Endogenous histamine inhibits the development of morphine-induced conditioned place preference

Acta Pharmacologica Sinica

Volumn 28, Issue 1, 2007, Pages 10-18

  Gong, Ying Xia ^a   Lv, Min ^a,b   Zhu, Yong Ping ^a   Zhu, Yuan Yuan ^a   Wei, Er Qing ^a   Shi, Hong ^b   Zeng, Qun Li ^a   Chen, Zhong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Conditioned place preference; Histamine; Morphine; Rat; Tuberomammillary nucleus

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; HISTAMINE; HISTIDINE; MORPHINE;

4 AMINOBUTYRIC ACID BRAIN LEVEL; AMINO ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN LEVEL; BRAIN NUCLEUS; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE ADDICTION; MORPHOLOGY; NERVE CELL; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; RAT; REWARD; SPRAGUE DAWLEY RAT; TUBEROMAMMILLARY NUCLEUS; VENTRAL TEGMENTUM;

EID: 33846016187     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00470.x     Document Type: Article

References (36)

1. Masukawa Y, Suzuki T, Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology (Berl) 1993; 111: 139-43.
2. Houdi AA, Bardo MT, Van Loon GR. Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res 1989; 497: 195-8.
3. Schechter MD, Calcagnetti DJ. Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci Biobehav Rev 1993; 17: 21-41.
4. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71: 1-51.
5. Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003; 4: 121-30.
6. Wada H, Inagaki N, Yamatodani A, Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity? Trends Neurosci 1991; 14: 415-8.
7. Panula P, Pirvola U, Auvinen S, Airaksinen MS. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 1989; 28: 585-610.
8. 2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 1998; 37: 1019-32.
9. Cohn CK, Ball GG, Hirsch J. Histamine: effect on self-stimulation. Science 1973; 180: 757-8.
10. Rassnick S, Kornetsky C. L-Histidine attenuates the effects of pentazocine on rewarding brain-stimulation. Life Sci 1991; 48: 1729-36.
11. Nath C, Patnaik GK, Saxena RC, Gupta MB. Evaluation of inhibitory effect of diphenhydramine on benzodiazepine dependence in rats. Indian J Physiol Pharmacol 1997; 41: 42-6.
12. Halpert AG, Olmstead MC, Beninger RJ. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci Biobehav Rev 2002; 26: 61-7.
13. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 4th ed. San Diego: Academic Press, 1998.
14. Jin CL, Yang LX, Wu XH, Li Q, Ding MP, Fan YY, et al. Effects of carnosine on amygdaloid kindled seizures in Sprague-Dawley rats. Neuroscience 2005; 135: 939-47.
15. Doyon WM, York JL, Diaz LM, Samson HH, Czachowski CL, Gonzales RA. Dopamine activity in the nucleus accumbens during consummatory phases of oral ethanol self-administration. Alcohol Clin Exp Res 2003; 27: 1573-82.
16. Moore KE, Demarest KT, Lookingland KJ. Stress, prolactin and hypothalamic dopaminergic neurons. Neuropharmacology 1987; 26: 801-8.
17. Mucha RF, van der Kooy D, O'Shaughnessy M, Bucenieks P. Drug reinforcement studied by the use of place conditioning in rat. Brain Res 1982; 243: 91-105.
18. Suzuki T, Funada M, Narita M, Misawa M, Nagase H. Morphine-induced place preference in the CXBK mouse: characteristics of μ-opioid receptor subtypes. Brain Res 1993; 602: 45-52.
19. Huang EY, Liu TC, Tao PL. Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens. Naunyn-Schmiedebergs Arch Pharmacol 2003; 368: 386-92.
20. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 1993; 264: 489-95.
21. Olmstead MC, Franklin KB. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci 1997; 111: 1324-34.
22. Onodera K, Yamatodani A, Watanabe T, Wada H. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disoders. Prog Neourobiol 1994; 42: 685-702.
23. Barke KE, Hough LB. Characterization of basal and morphine-induced histamine release in the rat periaqueductal gray. J Neurochem 1994; 63: 238-44.
24. Suzuki T, Takamori K, Misawa M, Onodera K. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res 1995; 675: 195-202.
25. Itzhak Y, Martin JL. Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice. Psychopharmacology (Berl) 2000; 52: 216-23.
26. Schroeder JP, Packard MG. Posttraining intra-basolateral amygdala scopolamine impairs food- and amphetamine-induced conditioned place preferences. Behav Neurosci 2002; 116: 922-7.
27. Kamei C, Tasaka K. Effect of histamine on memory retrieval in old rats. Biol Pharm Bull 1993; 16: 128-32.
28. Huang YW, Chen Z, Hu WW, Zhang LS, Wu W, Ying LY, et al. Facilitating effect of histamine on spatial memory deficits induced by dizocilpine as evaluated by 8-arm radial maze in SD rats. Acta Pharmacol Sin 2003; 24: 1270-6.
29. Wagner U, Weiler HT, Huston JP. Amplification of rewarding hypothalamic stimulation following a unilateral lesion in the region of the tuberomammillary nucleus. Neuroscience 1993; 52: 927-32.
30. Wagner U, Segura-Torres P, Weiler T, Huston JP. The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsihypothalamic self-stimulation by unilateral ibotenic acid lesions. Brain Res 1993; 613: 269-74.
31. Frisch C, Hasenohrl RU, Huston JP. Memory improvement by post-trial injection of lidocaine into the tuberomammillary nucleus, the source of neuronal histamine. Neurobiol Learn Mem 1999; 72: 69-77.
32. Kohler C, Swanson LW, Haglund L, Wu JY. The cytoarchitecture, histochemistry and projections of the tuberomammillary nucleus in the rat. Neuroscience 1985; 16: 85-110.
33. Bannon MJ, Roth RH. Pharmacology of mesocortical dopamine neuron. Pharmacol Rev 1983; 35: 53-68.
34. Fleckenstein AE, Lookingland KJ, Moore KE. Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors. Naunyn-Schmiedebergs Arch Pharmacol 1993; 347: 50-4.
35. Chiavegatto S, Nasello AG, Bernardi MM. Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci 1998; 62: 1875-88.
36. Huston JP, Wagner U, Hasenohrl RU. The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 1997; 83: 97-105.